Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Rho-Kinase
More Information »Rho-kinases (aka Rho-associated coiled-coil kinases or ROCKs) are serine/threonine kinases are activated by RhoA GTPases. They are modulators of processes involving cytoskeletal rearrangement such focal adhesion formation, cell motility and tumor cell invasion.
Rho-Kinase Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 0541 | Fasudil hydrochloride |
| Inhibitor of cyclic nucleotide dependent- and Rho-kinases | |
| 4009 | GSK 269962 |
| Potent and selective ROCK inhibitor | |
| 3726 | GSK 429286 |
| Selective Rho-kinase (ROCK) inhibitor | |
| 2414 | H 1152 dihydrochloride |
| Selective Rho-kinase (ROCK) inhibitor | |
| 2485 | Glycyl-H 1152 dihydrochloride |
| Selective Rho-kinase (ROCK) inhibitor. More selective analog of H 1152 dihydrochloride (Cat. No. 2414) | |
| 2415 | HA 1100 hydrochloride |
| Cell-permeable, selective Rho-kinase inhibitor | |
| 4118 | SB 772077B dihydrochloride |
| Potent Rho-kinase inhibitor; vasodilator | |
| 3667 | SR 3677 dihydrochloride |
| Potent, selective Rho-kinase (ROCK) inhibitor | |
| 1254 | Y-27632 dihydrochloride |
| Selective p160ROCK inhibitor | |
Related Categories
Quick Order
Find multiple products by catalog number
Cancer Research Guide
Request your free copy
Highlights over 350 products for cancer research. Request a copy or view PDF today.
Kinases Product Listing
Highlights over 350 products for kinase research. Request a copy or view PDF today.
Kinase Inhibitor Toolbox
80 Kinase inhibitors
pre-dissolved in DMSO
Some of the most potent
kinase inhibitors all on one plate
Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.
VEGF Pathway & Anti-Angiogenic Therapy
Written by N. Ferrara & Y. Crawford
A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.
Twitter Updates
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.